Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder

NACompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

September 30, 2013

Study Completion Date

July 31, 2014

Conditions
Major Depressive Disorder
Interventions
DEVICE

NeuroStar TMS

NeuroStar TMS treatmant - 120% of Observed MT, 10 pulses per second, 4 second on-time, 26 second off-time, 75 trains, 3,000 total pulses/sessions for 6 days. 3 treatments in taper week 1, 2 treatments in taper week 2 and 1 treatment in taper week 3.

Trial Locations (6)

21285

Sheppard Pratt Health System, Baltimore

29425

Medical University of South Carolina, Charleston

60612

Rush University Medical Center, Chicago

68526

Premier Psychiatric Group, L.L.C., Lincoln

98040

Center for Anxiety and Depression, Mercer Island

02906

Butler Hospital, Providence

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Neuronetics

OTHER

NCT01415154 - Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder | Biotech Hunter | Biotech Hunter